EOL care quality outcomes among Medicare beneficiaries with hematologic malignancies across major histology groups, stratified by hospice use. Proportion of patients dying in the acute care hospital (A), having an ICU admission in the last 30 days of life (B), or receiving chemotherapy in the last 14 days of life (C). (D) Mean number of days spent as an inpatient in the last 30 days of life. (E) Mean cumulative Medicare spending in the last 30 days of life. Vertical error bars represent 95% confidence intervals (CIs). Adjusted risk ratios (RR) and means ratios are from multivariable models in the aggregate cohort of all histologies, adjusting for age, sex, race/ethnicity, socioeconomic status, comorbidities, performance status, survival from diagnosis, and temporal trends.